Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized study

Bone Marrow Transplant. 2017 Jan;52(1):154-156. doi: 10.1038/bmt.2016.207. Epub 2016 Aug 15.

Authors

F Marchesi¹, A Tendas², D Giannarelli³, C Viggiani¹, S Gumenyuk¹, D Renzi¹, L Franceschini⁴, G Caffarella¹, M Rizzo⁴, F Palombi¹, F Pisani¹, A Romano¹, A Spadea¹, E Papa¹, M Canfora³, A Pignatelli¹, M Cantonetti⁴, W Arcese^{4

5}, A Mengarelli¹

Affiliations

¹ Hematology and Stem Cell Transplant Unit, Regina Elena National Cancer Institute, Rome, Italy.
² Hematology, S Eugenio Hospital, Rome, Italy.
³ Biostatistics Unit, Regina Elena National Cancer Institute, Rome, Italy.
⁴ Hematology Unit, Tor Vergata University, Rome, Italy.
⁵ Rome Transplant Network, Rome, Italy.

PMID: 27526285
DOI: 10.1038/bmt.2016.207

No abstract available

Publication types

Letter
Randomized Controlled Trial

MeSH terms

Adult
Aged
Cryotherapy / methods*
Female
Hematopoietic Stem Cell Transplantation / adverse effects*
Hematopoietic Stem Cell Transplantation / methods
Humans
Male
Melphalan / adverse effects*
Middle Aged
Multiple Myeloma / complications*
Prospective Studies
Stomatitis / etiology*
Stomatitis / pathology
Transplantation, Autologous / adverse effects*
Transplantation, Autologous / methods

Substances

Melphalan